Structure

InChI Key PHIQHXFUZVPYII-ZCFIWIBFSA-N
Smile C[N+](C)(C)C[C@H](O)CC(=O)[O-]
InChI
InChI=1S/C7H15NO3/c1-8(2,3)5-6(9)4-7(10)11/h6,9H,4-5H2,1-3H3/t6-/m1/s1

Physicochemical Descriptors

Property Name Value
Molecular Formula C7H15NO3
Molecular Weight 161.2
AlogP -1.81
Hydrogen Bond Acceptor 3.0
Hydrogen Bond Donor 1.0
Number of Rotational Bond 4.0
Polar Surface Area 60.36
Molecular species ACID
Aromatic Rings 0.0
Heavy Atoms 11.0

Pharmacology

Targets EC50(nM) IC50(nM) Kd(nM) Ki(nM) Inhibition(%)
Enzyme Transferase
- - - 100000 -

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Pyelonephritis 3 D011704 ClinicalTrials
Lipid Metabolism Disorders 3 D052439 ClinicalTrials
Atrial Fibrillation 3 D001281 ClinicalTrials
Peripheral Arterial Disease 3 D058729 ClinicalTrials
Pancreatic Neoplasms 3 D010190 ClinicalTrials
Multiple Sclerosis 3 D009103 ClinicalTrials
HIV Infections 3 D015658 ClinicalTrials
Sarcopenia 3 D055948 ClinicalTrials
Gastrointestinal Stromal Tumors 3 D046152 ClinicalTrials
Muscular Atrophy, Spinal 3 D009134 ClinicalTrials
Hyperthyroidism 3 D006980 ClinicalTrials
Cytomegalovirus Infections 3 D003586 ClinicalTrials
Acute Kidney Injury 3 D058186 ClinicalTrials
Spinal Cord Injuries 2 D013119 ClinicalTrials
Heart Failure 2 D006333 ClinicalTrials
beta-Thalassemia 2 D017086 ClinicalTrials
Renal Insufficiency, Chronic 2 D051436 ClinicalTrials
Diabetes Mellitus, Type 2 2 D003924 ClinicalTrials
Non-alcoholic Fatty Liver Disease 2 D065626 ClinicalTrials
Acquired Immunodeficiency Syndrome 2 D000163 ClinicalTrials
Neoplasms 2 D009369 ClinicalTrials
Polycystic Ovary Syndrome 2 D011085 ClinicalTrials
Muscle Cramp 2 D009120 ClinicalTrials
Shock, Septic 1 D012772 ClinicalTrials

Related Entries

MCS

Adverse Reactions

System Organ Classification (SOC)
Relative Frequency (%)
General disorders and administration site conditions
11.94
Nervous system disorders
11.08
Gastrointestinal disorders
8.35
Metabolism and nutrition disorders
7.34
Musculoskeletal and connective tissue disorders
6.91
Injury, poisoning and procedural complications
6.62
Vascular disorders
6.19
Respiratory, thoracic and mediastinal disorders
6.04
Investigations
5.61
Cardiac disorders
4.89
Psychiatric disorders
4.03
Skin and subcutaneous tissue disorders
3.88
Hepatobiliary disorders
3.31
Infections and infestations
3.31
Renal and urinary disorders
2.88

Cross References

Resources Reference
CAS NUMBER 541-15-1
ChEBI 16347
ChEMBL CHEMBL1149
DrugBank DB00583
DrugCentral 513
EPA CompTox DTXSID4023208
FDA SRS 0G389FZZ9M
Human Metabolome Database HMDB0000062
Guide to Pharmacology 4780
KEGG C00318
PDB 152
PharmGKB PA450154
PubChem 10917
SureChEMBL SCHEMBL21970
ZINC ZINC03079340